查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2108326

醫藥物流市場分析及至2035年的預測：依類型、產品、服務、技術、組件、應用、設備、運輸方式及階段

Pharmaceutical Logistics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Equipment, Mode, Stage
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球醫藥物流市場預計將從2025年的1,077億美元成長到2035年的2,449億美元，CAGR為8.5%。該市場集中度適中，冷鏈物流在該領域佔據主導地位，這主要得益於疫苗、生物製藥和特種藥物對溫控運輸需求的不斷成長。此外，市場正日益廣泛地採用基於物聯網的追蹤、自動化和即時監控等先進技術，以提高供應鏈的透明度和合規性。全球物流供應商正透過投資和收購不斷拓展其在醫療保健領域的業務能力，形成競爭格局。例如，DHL Group在2025年4月宣布，將在2030年前投資20億美元，以增強DHL Health Logistics的能力，包括擴展其冷鏈基礎設施、溫控倉儲以及針對生物製藥和細胞/基因療法的專業物流解決方案。策略聯盟、數位轉型以及對可靠藥品分銷網路日益成長的需求，將持續推動市場發展。

依類型分析，2025年醫藥物流市場中，冷鏈物流細分市場的發展主要受疫苗、生物製藥、細胞和基因療法等溫度敏感型藥品對溫控運輸和儲存解決方案需求成長的驅動。冷鏈物流透過確保嚴格的溫度控制和合規性，在整個供應鏈中發揮維持產品穩定性、安全性和有效性的關鍵作用。生物製藥的日益普及、藥品出口的成長以及對先進冷凍技術投資的增加，進一步強化了對冷鏈解決方案的需求。全球醫療保健供應鏈的擴張和日益嚴格的品質要求，也持續鞏固了冷鏈物流的主導地位。

市場區隔
類型 冷鏈物流、非冷鏈物流、其他
產品 疫苗、生物製藥、臨床試驗樣本、非處方藥、處方藥、血液製品、細胞和基因治療產品、其他
服務 運輸、倉儲、包裝、庫存管理、訂單處理、清關、其他
技術 物聯網、區塊鏈、人工智慧和機器學習、機器人技術、雲端運算、自動化、其他
組件 軟體、硬體、服務、其他
用途 醫院和診所、製藥公司、研究機構、生技公司、其他
裝置 冷藏貨櫃、溫度監控設備、其他
交通工具 空運、海運、陸運、鐵路運輸、其他
階段 製造、分銷、零售、其他

依產品細分市場來看，細胞和基因治療產品細分市場預計將在預測期內呈現最高的成長率，活性化、臨床試驗的增加以及先進療法商業化的進展。細胞和基因療法產品需要高度專業化的物流解決方案，包括低溫儲存、即時監控和客製化的運輸流程，以確保產品的完整性。創新療法的核准數量不斷增加、生物技術研發管線的擴展以及對個人化醫療投資的持續成長，加速專業醫藥物流服務的需求。對這些複雜療法的安全、可追溯且受監管的運輸解決方案日益成長的需求，預計將推動該細分市場的快速擴張。

區域概覽

北美佔據全球醫藥物流市場最大佔有率，這得益於其先進的醫療基礎設施、龐大的藥品產量以及對溫控供應鏈解決方案的強勁需求。美國是市場領導者，這主要得益於其成熟的醫藥和生物技術生態系統、生技藥品日益普及以及對醫療物流基礎設施的大量投資。加拿大也透過其不斷擴展的藥品生產和分銷網路為市場做出貢獻。該地區受益於嚴格的監管標準、先進的冷鏈能力以及數位化物流技術的廣泛應用，包括即時監控和自動化倉庫解決方案，這些都提高了供應鏈效率和產品安全性。

亞太地區預計將成為醫藥物流市場成長最快的地區，其主要驅動力包括藥品生產規模的擴大、醫療保健支出的成長、生物製藥需求的增加以及醫療基礎設施的改善。中國和印度等國家是成長的主要動力，它們擁有大規模的藥品生產能力，學名藥出口不斷擴大，並且增加了對冷鏈物流網路的投資。日本、韓國和東南亞國家也採用先進的物流解決方案來支援特種藥品和臨床試驗樣本的運輸。快速的都市化、醫療保健服務的改善以及不斷擴大的醫藥貿易活動預計將進一步加速該地區的市場成長。

主要趨勢和促進因素

醫藥物流數位轉型進展：

透過採用物聯網（IoT）、人工智慧（AI）、區塊鏈和雲端平台等先進技術，醫藥物流市場正經歷加速的數位轉型。這些技術提高了供應鏈的透明度，實現了藥品運輸的即時追蹤，並增強了對溫度敏感型產品的溫度監控能力。物聯網設備有助於維持必要的儲存條件，而人工智慧和分析技術則支援需求預測、路線最佳化和庫存管理。區塊鏈解決方案也用於提高可追溯性並降低假冒風險。對透明、高效且合規的醫藥供應鏈日益成長的需求，加速數位化解決方案在整個物流營運中的整合。

對冷鏈物流解決方案的需求日益成長：

在醫藥物流市場，生物製藥、疫苗、細胞和基因療法等對溫度敏感的產品生產和分銷的不斷成長，推動了對冷鏈物流解決方案的需求。這些產品需要專門的儲存、運輸和監控系統，以確保整個供應鏈的安全性和有效性。製藥公司和物流供應商投資先進的冷凍技術、溫控包裝和即時監控解決方案，以提高產品的完整性。生物製藥產品線的擴展、個人化醫療的興起以及特種藥品在全球範圍內的分銷日益廣泛，預計將進一步增加對可靠冷鏈基礎設施的需求。

目錄

第1章 執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機會
  • 市場限制因素
  • 年複合成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 冷鏈物流
    • 非冷鏈物流
    • 其他
  • 市場規模及預測：依產品分類
    • 疫苗
    • 生物製藥
    • 臨床試驗材料
    • 非處方藥
    • 處方藥
    • 血液製品
    • 細胞和基因療法產品
    • 其他
  • 市場規模及預測：依服務分類
    • 運輸
    • 倉儲
    • 包裝
    • 庫存管理
    • 訂單處理
    • 報關
    • 其他
  • 市場規模及預測：依技術分類
    • IoT
    • 區塊鏈
    • 人工智慧和機器學習
    • 機器人技術
    • 雲端運算
    • 自動化
    • 其他
  • 市場規模及預測：依組件分類
    • 軟體
    • 硬體
    • 服務
    • 其他
  • 市場規模及預測：依應用領域分類
    • 醫院和診所
    • 製藥公司
    • 研究機構
    • 生技公司
    • 其他
  • 市場規模及預測：依運輸方式分類
    • 空運貨物
    • 海上運輸
    • 公路貨運
    • 鐵路貨運
    • 其他
  • 市場規模及預測：依階段分類
    • 製造
    • 分銷
    • 零售
    • 其他
  • 市場規模及預測：依設備類型分類
    • 冷藏貨櫃
    • 溫度監測裝置
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要公司的策略

第8章 公司簡介

  • DHL Supply Chain
  • Kuehne Nagel
  • UPS Supply Chain Solutions
  • FedEx Logistics
  • DB Schenker
  • CH Robinson
  • XPO Logistics
  • Nippon Express
  • DSV
  • GEODIS
  • CEVA Logistics
  • Agility Logistics
  • Panalpina
  • Kerry Logistics
  • Expeditors International
  • Sinotrans
  • Bollore Logistics
  • Hellmann Worldwide Logistics
  • Yusen Logistics
  • Rhenus Logistics

第9章 關於我們

簡介目錄
Product Code: GIS21383

The global Pharmaceutical Logistics Market is projected to grow from $107.7 billion in 2025 to $244.9 billion by 2035, at a compound annual growth rate (CAGR) of 8.5%. The Pharmaceutical Logistics Market is moderately consolidated, with cold chain logistics representing the leading segment due to the growing need for temperature-controlled transportation of vaccines, biologics, and specialty medicines. The market is witnessing increased adoption of advanced technologies such as IoT-based tracking, automation, and real-time monitoring to improve supply chain visibility and regulatory compliance. The competitive landscape includes global logistics providers expanding their healthcare capabilities through investments and acquisitions. For instance, in April 2025, DHL Group announced a 2 billion investment by 2030 to enhance DHL Health Logistics capabilities, including expanding cold chain infrastructure, temperature-controlled storage, and specialized logistics solutions for biopharmaceuticals and cell and gene therapies.The market continues to evolve through strategic partnerships, digital transformation, and growing demand for reliable pharmaceutical distribution networks.

Based on Type, the Cold Chain Logistics segment dominated the Pharmaceutical Logistics Market in 2025 due to the increasing demand for temperature-controlled transportation and storage solutions for sensitive pharmaceutical products such as vaccines, biologics, and cell and gene therapies. Cold chain logistics plays a critical role in maintaining product stability, safety, and efficacy throughout the supply chain by ensuring strict temperature monitoring and regulatory compliance. Growing adoption of biologics, rising pharmaceutical exports, and increasing investments in advanced refrigeration technologies are further strengthening the demand for cold chain solutions. The expansion of global healthcare supply networks and stringent quality requirements continue to support the leadership position of cold chain logistics.

Market Segmentation
TypeCold Chain Logistics, Non-Cold Chain Logistics, Others
ProductVaccines, Biopharmaceuticals, Clinical Trial Materials, OTC Drugs, Prescription Drugs, Blood Products, Cell and Gene Therapy Products, Others
ServicesTransportation, Warehousing, Packaging, Inventory Management, Order Fulfillment, Customs Brokerage, Others
TechnologyIoT, Blockchain, AI and Machine Learning, Robotics, Cloud Computing, Automation, Others
ComponentSoftware, Hardware, Services, Others
ApplicationHospital and Clinics, Pharmaceutical Companies, Research Institutes, Biotechnology Companies, Others
EquipmentRefrigerated Containers, Temperature Monitoring Devices, Others
ModeAir Freight, Sea Freight, Road Freight, Rail Freight, Others
StageManufacturing, Distribution, Retail, Others

Based on Product, the Cell and Gene Therapy Products segment is projected to register the fastest growth during the forecast period, driven by increasing research activities, rising clinical trials, and growing commercialization of advanced therapies. Cell and gene therapies require highly specialized logistics solutions, including ultra-low temperature storage, real-time monitoring, and customized transportation processes to preserve product integrity. Increasing approvals of innovative therapies, expanding biotechnology pipelines, and rising investments in personalized medicine are accelerating demand for specialized pharmaceutical logistics services. The growing need for secure, traceable, and compliant transportation solutions for these complex therapies is expected to drive rapid segment expansion.

Geographical Overview

North America holds the largest share of the pharmaceutical logistics market, supported by advanced healthcare infrastructure, high pharmaceutical production, and strong demand for temperature-controlled supply chain solutions. The United States is the leading contributor, driven by a well-established pharmaceutical and biotechnology ecosystem, increasing adoption of biologics, and significant investments in healthcare logistics infrastructure. Canada also contributes through its expanding pharmaceutical manufacturing and distribution networks. The region benefits from stringent regulatory standards, advanced cold chain capabilities, and widespread adoption of digital logistics technologies, including real-time monitoring and automated warehouse solutions, which enhance supply chain efficiency and product safety.

Asia-Pacific is projected to be the fastest-growing region in the pharmaceutical logistics market, driven by expanding pharmaceutical manufacturing, rising healthcare expenditure, increasing demand for biologics, and improving healthcare infrastructure. Countries such as China and India are key growth contributors due to their large-scale pharmaceutical production capabilities, growing generic drug exports, and increasing investments in cold chain logistics networks. Japan, South Korea, and Southeast Asian countries are also witnessing increased adoption of advanced logistics solutions to support specialty medicines and clinical trial materials. Rapid urbanization, rising healthcare access, and growing pharmaceutical trade activities are expected to accelerate regional market expansion.

Key Trends and Drivers

Increasing Digital Transformation in Pharmaceutical Logistics:

The pharmaceutical logistics market is witnessing increasing digital transformation through the adoption of advanced technologies such as Internet of Things (IoT), artificial intelligence (AI), blockchain, and cloud-based platforms. These technologies are improving supply chain visibility, enabling real-time tracking of pharmaceutical shipments, and enhancing temperature monitoring for sensitive products. IoT-enabled devices help maintain required storage conditions, while AI and analytics support demand forecasting, route optimization, and inventory management. Blockchain solutions are also gaining adoption to improve traceability and reduce counterfeit risks. The growing need for transparent, efficient, and compliant pharmaceutical supply chains is accelerating the integration of digital solutions across logistics operations.

Growing Demand for Cold Chain Logistics Solutions:

The pharmaceutical logistics market is experiencing growing demand for cold chain logistics solutions due to the increasing production and distribution of temperature-sensitive products, including biologics, vaccines, and cell and gene therapies. These products require specialized storage, transportation, and monitoring systems to maintain their safety and effectiveness throughout the supply chain. Pharmaceutical companies and logistics providers are investing in advanced refrigeration technologies, temperature-controlled packaging, and real-time monitoring solutions to improve product integrity. The expansion of biologics pipelines, rising adoption of personalized medicines, and increasing global distribution of specialty drugs are expected to further drive the demand for reliable cold chain infrastructure.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Mode
  • 2.8 Key Market Highlights by Stage
  • 2.9 Key Market Highlights by Equipment

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Cold Chain Logistics
    • 4.1.2 Non-Cold Chain Logistics
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Vaccines
    • 4.2.2 Biopharmaceuticals
    • 4.2.3 Clinical Trial Materials
    • 4.2.4 OTC Drugs
    • 4.2.5 Prescription Drugs
    • 4.2.6 Blood Products
    • 4.2.7 Cell and Gene Therapy Products
    • 4.2.8 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Transportation
    • 4.3.2 Warehousing
    • 4.3.3 Packaging
    • 4.3.4 Inventory Management
    • 4.3.5 Order Fulfillment
    • 4.3.6 Customs Brokerage
    • 4.3.7 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 IoT
    • 4.4.2 Blockchain
    • 4.4.3 AI and Machine Learning
    • 4.4.4 Robotics
    • 4.4.5 Cloud Computing
    • 4.4.6 Automation
    • 4.4.7 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software
    • 4.5.2 Hardware
    • 4.5.3 Services
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Hospital and Clinics
    • 4.6.2 Pharmaceutical Companies
    • 4.6.3 Research Institutes
    • 4.6.4 Biotechnology Companies
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Mode (2020-2035)
    • 4.7.1 Air Freight
    • 4.7.2 Sea Freight
    • 4.7.3 Road Freight
    • 4.7.4 Rail Freight
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Stage (2020-2035)
    • 4.8.1 Manufacturing
    • 4.8.2 Distribution
    • 4.8.3 Retail
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Equipment (2020-2035)
    • 4.9.1 Refrigerated Containers
    • 4.9.2 Temperature Monitoring Devices
    • 4.9.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Mode
      • 5.2.1.8 Stage
      • 5.2.1.9 Equipment
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Mode
      • 5.2.2.8 Stage
      • 5.2.2.9 Equipment
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Mode
      • 5.2.3.8 Stage
      • 5.2.3.9 Equipment
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Mode
      • 5.3.1.8 Stage
      • 5.3.1.9 Equipment
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Mode
      • 5.3.2.8 Stage
      • 5.3.2.9 Equipment
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Mode
      • 5.3.3.8 Stage
      • 5.3.3.9 Equipment
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Mode
      • 5.4.1.8 Stage
      • 5.4.1.9 Equipment
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Mode
      • 5.4.2.8 Stage
      • 5.4.2.9 Equipment
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Mode
      • 5.4.3.8 Stage
      • 5.4.3.9 Equipment
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Mode
      • 5.4.4.8 Stage
      • 5.4.4.9 Equipment
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Mode
      • 5.4.5.8 Stage
      • 5.4.5.9 Equipment
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Mode
      • 5.4.6.8 Stage
      • 5.4.6.9 Equipment
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Mode
      • 5.4.7.8 Stage
      • 5.4.7.9 Equipment
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Mode
      • 5.5.1.8 Stage
      • 5.5.1.9 Equipment
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Mode
      • 5.5.2.8 Stage
      • 5.5.2.9 Equipment
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Mode
      • 5.5.3.8 Stage
      • 5.5.3.9 Equipment
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Mode
      • 5.5.4.8 Stage
      • 5.5.4.9 Equipment
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Mode
      • 5.5.5.8 Stage
      • 5.5.5.9 Equipment
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Mode
      • 5.5.6.8 Stage
      • 5.5.6.9 Equipment
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Mode
      • 5.6.1.8 Stage
      • 5.6.1.9 Equipment
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Mode
      • 5.6.2.8 Stage
      • 5.6.2.9 Equipment
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Mode
      • 5.6.3.8 Stage
      • 5.6.3.9 Equipment
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Mode
      • 5.6.4.8 Stage
      • 5.6.4.9 Equipment
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Mode
      • 5.6.5.8 Stage
      • 5.6.5.9 Equipment

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 DHL Supply Chain
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Kuehne Nagel
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 UPS Supply Chain Solutions
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 FedEx Logistics
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 DB Schenker
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 C.H. Robinson
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 XPO Logistics
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Nippon Express
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 DSV
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 GEODIS
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 CEVA Logistics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Agility Logistics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Panalpina
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Kerry Logistics
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Expeditors International
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Sinotrans
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Bollore Logistics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Hellmann Worldwide Logistics
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Yusen Logistics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Rhenus Logistics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us